Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01841931 · ClinicalTrials.gov registry record · Phase 4
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
A Phase 4 study, sponsored by Theresa Jacob, PhD, MPH.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT01841931 is a Phase 4 study that was terminated before completion, run by Theresa Jacob, PhD, MPH. The registered enrollment target is 4 participants.
The verdict
NCT01841931, a Phase 4 study, was terminated before completion, sponsored by Theresa Jacob, PhD, MPH.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether buprenorphine can be at least as effective as other opioid medications in relieving chronic pain in patients who suffer from dependence on their opioid medications, while patients simultaneously experience progressive decline of pain along with absence of opioid withdrawal symptoms and improved quality of life.
Interventions
- DRUG Buprenorphine/Naloxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01841931
The ClinicalTrials.gov registry entry for NCT01841931 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theresa Jacob, PhD, MPH, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine/Naloxone is the first listed.
NCT01841931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01841931 about?
NCT01841931 is a clinical study titled "Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients". The purpose of this study is to examine whether buprenorphine can be at least as effective as other opioid medications in relieving chronic pain in patients who suffer from dependence on their opioid medications, while patients simultaneously experience progressive decline of pain along with absence...
What is the current status of trial NCT01841931?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2013-02. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01841931?
The interventions under investigation include: Buprenorphine/Naloxone (DRUG).
Who is sponsoring clinical trial NCT01841931?
This trial is sponsored by Theresa Jacob, PhD, MPH, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.